Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration

Alessandra Latini, A. Bonadies, E. Trento, S. Bultrini, C. Cota, F. M. Solivetti, C. Ferraro, M. Ardigò, B. Amorosi, G. Palamara, S. Bucher, M. Giuliani, P. Cordiali-Fei, F. Ensoli, A. Di Carlo

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The present prospective study was aimed at evaluating the long-term efficacy of local electrochemotherapy (ECT) with the intravenous administration of bleomycin, on disease progression and viral activity in classic Kaposi's sarcoma (cKS), a vascular tumor related to human herpes virus-8 infection. Eighteen patients affected by isolate or multiple cutaneous lesions, refractory to conventional treatments, although in the absence of visceral involvement, were enrolled in a study. Follow-up visits were performed after 4 weeks and every 6 months for up to 48 months. A more extensive exploration of the immunologic status as well as of virological parameters was performed in nine patients. The results showed a significant clinical improvement in all patients after 4 weeks. A complete regression was observed in 12 patients after the first ECT, while four patients required a second treatment on the residual lesions after 4 weeks from the first intervention. The positive outcome persisted during the subsequent clinical control visits. Two patients, that showed rapidly evolving did not improve and relapsed despite a second round of ECT treatment. Effective treatment was associated with the reduction of viral load to undetectable levels. These data support the conduct of larger studies directed at validating the efficacy of ECT as a first-line therapy for cKS.

Original languageEnglish
Pages (from-to)214-218
Number of pages5
JournalDermatologic Therapy
Volume25
Issue number2
DOIs
Publication statusPublished - Mar 2012

Fingerprint

Electrochemotherapy
Kaposi's Sarcoma
Bleomycin
Intravenous Administration
Therapeutics
Virus Diseases
Viral Load
Blood Vessels
Disease Progression
Prospective Studies
Skin

Keywords

  • Classic KS
  • Elettrochemotherapy
  • HHV-8

ASJC Scopus subject areas

  • Dermatology

Cite this

Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration. / Latini, Alessandra; Bonadies, A.; Trento, E.; Bultrini, S.; Cota, C.; Solivetti, F. M.; Ferraro, C.; Ardigò, M.; Amorosi, B.; Palamara, G.; Bucher, S.; Giuliani, M.; Cordiali-Fei, P.; Ensoli, F.; Di Carlo, A.

In: Dermatologic Therapy, Vol. 25, No. 2, 03.2012, p. 214-218.

Research output: Contribution to journalArticle

Latini, A, Bonadies, A, Trento, E, Bultrini, S, Cota, C, Solivetti, FM, Ferraro, C, Ardigò, M, Amorosi, B, Palamara, G, Bucher, S, Giuliani, M, Cordiali-Fei, P, Ensoli, F & Di Carlo, A 2012, 'Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration', Dermatologic Therapy, vol. 25, no. 2, pp. 214-218. https://doi.org/10.1111/j.1529-8019.2012.01437.x
Latini, Alessandra ; Bonadies, A. ; Trento, E. ; Bultrini, S. ; Cota, C. ; Solivetti, F. M. ; Ferraro, C. ; Ardigò, M. ; Amorosi, B. ; Palamara, G. ; Bucher, S. ; Giuliani, M. ; Cordiali-Fei, P. ; Ensoli, F. ; Di Carlo, A. / Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration. In: Dermatologic Therapy. 2012 ; Vol. 25, No. 2. pp. 214-218.
@article{a6afa421432e4604b081df1b01fb95a5,
title = "Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration",
abstract = "The present prospective study was aimed at evaluating the long-term efficacy of local electrochemotherapy (ECT) with the intravenous administration of bleomycin, on disease progression and viral activity in classic Kaposi's sarcoma (cKS), a vascular tumor related to human herpes virus-8 infection. Eighteen patients affected by isolate or multiple cutaneous lesions, refractory to conventional treatments, although in the absence of visceral involvement, were enrolled in a study. Follow-up visits were performed after 4 weeks and every 6 months for up to 48 months. A more extensive exploration of the immunologic status as well as of virological parameters was performed in nine patients. The results showed a significant clinical improvement in all patients after 4 weeks. A complete regression was observed in 12 patients after the first ECT, while four patients required a second treatment on the residual lesions after 4 weeks from the first intervention. The positive outcome persisted during the subsequent clinical control visits. Two patients, that showed rapidly evolving did not improve and relapsed despite a second round of ECT treatment. Effective treatment was associated with the reduction of viral load to undetectable levels. These data support the conduct of larger studies directed at validating the efficacy of ECT as a first-line therapy for cKS.",
keywords = "Classic KS, Elettrochemotherapy, HHV-8",
author = "Alessandra Latini and A. Bonadies and E. Trento and S. Bultrini and C. Cota and Solivetti, {F. M.} and C. Ferraro and M. Ardig{\`o} and B. Amorosi and G. Palamara and S. Bucher and M. Giuliani and P. Cordiali-Fei and F. Ensoli and {Di Carlo}, A.",
year = "2012",
month = "3",
doi = "10.1111/j.1529-8019.2012.01437.x",
language = "English",
volume = "25",
pages = "214--218",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Blackwell Publishing Inc.",
number = "2",

}

TY - JOUR

T1 - Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration

AU - Latini, Alessandra

AU - Bonadies, A.

AU - Trento, E.

AU - Bultrini, S.

AU - Cota, C.

AU - Solivetti, F. M.

AU - Ferraro, C.

AU - Ardigò, M.

AU - Amorosi, B.

AU - Palamara, G.

AU - Bucher, S.

AU - Giuliani, M.

AU - Cordiali-Fei, P.

AU - Ensoli, F.

AU - Di Carlo, A.

PY - 2012/3

Y1 - 2012/3

N2 - The present prospective study was aimed at evaluating the long-term efficacy of local electrochemotherapy (ECT) with the intravenous administration of bleomycin, on disease progression and viral activity in classic Kaposi's sarcoma (cKS), a vascular tumor related to human herpes virus-8 infection. Eighteen patients affected by isolate or multiple cutaneous lesions, refractory to conventional treatments, although in the absence of visceral involvement, were enrolled in a study. Follow-up visits were performed after 4 weeks and every 6 months for up to 48 months. A more extensive exploration of the immunologic status as well as of virological parameters was performed in nine patients. The results showed a significant clinical improvement in all patients after 4 weeks. A complete regression was observed in 12 patients after the first ECT, while four patients required a second treatment on the residual lesions after 4 weeks from the first intervention. The positive outcome persisted during the subsequent clinical control visits. Two patients, that showed rapidly evolving did not improve and relapsed despite a second round of ECT treatment. Effective treatment was associated with the reduction of viral load to undetectable levels. These data support the conduct of larger studies directed at validating the efficacy of ECT as a first-line therapy for cKS.

AB - The present prospective study was aimed at evaluating the long-term efficacy of local electrochemotherapy (ECT) with the intravenous administration of bleomycin, on disease progression and viral activity in classic Kaposi's sarcoma (cKS), a vascular tumor related to human herpes virus-8 infection. Eighteen patients affected by isolate or multiple cutaneous lesions, refractory to conventional treatments, although in the absence of visceral involvement, were enrolled in a study. Follow-up visits were performed after 4 weeks and every 6 months for up to 48 months. A more extensive exploration of the immunologic status as well as of virological parameters was performed in nine patients. The results showed a significant clinical improvement in all patients after 4 weeks. A complete regression was observed in 12 patients after the first ECT, while four patients required a second treatment on the residual lesions after 4 weeks from the first intervention. The positive outcome persisted during the subsequent clinical control visits. Two patients, that showed rapidly evolving did not improve and relapsed despite a second round of ECT treatment. Effective treatment was associated with the reduction of viral load to undetectable levels. These data support the conduct of larger studies directed at validating the efficacy of ECT as a first-line therapy for cKS.

KW - Classic KS

KW - Elettrochemotherapy

KW - HHV-8

UR - http://www.scopus.com/inward/record.url?scp=84862527580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862527580&partnerID=8YFLogxK

U2 - 10.1111/j.1529-8019.2012.01437.x

DO - 10.1111/j.1529-8019.2012.01437.x

M3 - Article

C2 - 22741941

AN - SCOPUS:84862527580

VL - 25

SP - 214

EP - 218

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 2

ER -